About: Effects of enalapril and neuroendocrine activation on prognosis in severe congestive heart failure (follow-up of the CONSENSUS trial). CONSENSUS Trial Study Group

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Effects of enalapril and neuroendocrine activation on prognosis in severe congestive heart failure (follow-up of the CONSENSUS trial). CONSENSUS Trial Study Group Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 October 1990

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в жовтні 1990 (uk) im Oktober 1990 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'ochobre de 1990 (ast) scientific article published on 01 October 1990 (en)
publication date	wds:Q68572827-C7DD00B9-DC96-4B5D-9C5E-F73536484B66
publication date	1990-10-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q68572827-0C7FF68D-A756-4759-A12F-2C3D35790361
language of work or name	English
author name string	wds:Q68572827-00CF8CB3-DAB2-480A-9922-30F9F9F9887A wds:Q68572827-EB63CBD7-6C56-45F9-B694-0875FB102921
author name string	P Eneroth S Snapinn
rdfs:label	Effects of enalapril and neuroendocrine activation on prognosis in severe congestive heart failure (follow-up of the CONSENSUS trial). CONSENSUS Trial Study Group (en) Effects of enalapril and neuroendocrine activation on prognosis in severe congestive heart failure (nl)
skos:prefLabel	Effects of enalapril and neuroendocrine activation on prognosis in severe congestive heart failure (follow-up of the CONSENSUS trial). CONSENSUS Trial Study Group (en) Effects of enalapril and neuroendocrine activation on prognosis in severe congestive heart failure (nl)
name	Effects of enalapril and neuroendocrine activation on prognosis in severe congestive heart failure (follow-up of the CONSENSUS trial). CONSENSUS Trial Study Group (en) Effects of enalapril and neuroendocrine activation on prognosis in severe congestive heart failure (nl)
author	wds:Q68572827-AF34E232-B98F-4FB7-90E5-B4DE1B0A76C3 wds:Q68572827-D890A6C9-83B2-4764-B3A4-CB0B7B670D66
author	John Kjekshus Karl Swedberg
title	wds:Q68572827-924C3900-2C9F-42F0-9FC0-EC4165328226
title	Effects of enalapril and neuroendocrine activation on prognosis in severe congestive heart failure (follow-up of the CONSENSUS trial). CONSENSUS Trial Study Group (en)
page(s)	wds:Q68572827-FB7D874D-46DD-4717-9E8C-27761BCD5475
page(s)	40D-44D; discussion 44D-45D
instance of	wds:Q68572827-4A081012-9935-4D28-A023-429470041C3B
instance of	scholarly article
main subject	wds:Q68572827-5C112A64-0601-485B-A300-E48B92025EF5 wds:Q68572827-6652D47E-036C-4B28-985B-7BA2B77FE0F2 wds:Q68572827-AC1D635B-CD19-4715-B590-8E115E5C1E5C
main subject	enalapril heart failure congestive heart failure
PubMed ID	wds:Q68572827-8E929770-98A0-469A-BFFC-DE06E7E36978
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2220604
PubMed ID	2220604
published in	wds:Q68572827-F1E78AC2-1AC6-4BB7-B1A9-C13230250B09
published in	American Journal of Cardiology
issue	wds:Q68572827-0E2572AA-5A1E-42A1-A71F-E5C8D2A4FF66
volume	wds:Q68572827-43D5BC8C-1A4F-4636-B1F4-568A0150DD97
issue	11
volume	66
DOI	wds:Q68572827-288F484E-BEED-4905-A3D3-87049EA1273E
DOI	http://dx.doi.org/10.1016/0002-9149(90)90475-G
DOI	10.1016/0002-9149(90)90475-G
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q68572827
is cites work of	ACE inhibitors in pediatric patients with heart failure The effect of treatment with angiotensin-converting enzyme inhibitors on survival of pediatric patients with dilated cardiomyopathy Effect of angiotensin-converting enzyme gene polymorphism on left ventricular remodeling after anteroseptal infarction. Differences in generalist and specialist physicians' knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype Renal dysfunction in heart failure patients: what is the evidence? Pathophysiology and clinical evaluation of acute heart failure Differential Effect of Acute Baroreceptor Unloading on Cardiac and Systemic Sympathetic Tone in Congestive Heart Failure Activation of ENaC by AVP contributes to the urinary concentrating mechanism and dilution of plasma. An aldosterone synthase gene variant is associated with improvement in left ventricular ejection fraction in dilated cardiomyopathy. Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure Heart failure--the importance of ethnicity Neurohormonal activation and inflammation in chronic cardiopulmonary disease: a brief systematic review Aldosterone breakthrough during RAS blockade: a role for endothelins and their antagonists? Late recovery of ventricular function in children with idiopathic dilated cardiomyopathy Time-related adaptations in plasma neurohormone levels and hemodynamics after myocardial infarction in the rat Heart failure in subjects with chronic kidney disease: Best management practices Shifts in mortality curves Hemodynamic and hormonal effects of quinaprilat in patients with congestive heart failure Medical Management of Heart Failure With Reduced Ejection Fraction in Patients With Advanced Renal Disease Plasma catecholamine levels parallel severity of heart failure and have prognostic value in children with dilated cardiomyopathy Therapies for acute heart failure in patients with reduced kidney function: a community-based perspective The treatment of heart failure--what next? Pharmacologic management of heart failure: neurohormonal agents Changing Strategies in the Management of Chronic Congestive Heart Failure
is cites work of	wds:Q77212728-7E9106BB-9141-4A03-B7D6-8C54AB794072 wds:Q34390665-0B900CC6-790B-46EA-810B-9DD2C05D1670 wds:Q63479551-E4D4733E-832B-4F3A-AB2E-BEC2F404B3BA wds:Q73299625-51DC1715-A536-4CB3-8DA8-59620C841606 wds:Q91700940-F0D7E62F-5521-406C-9CB4-DCE0457DD53C wds:Q39493510-7683076F-A274-40F3-849C-EB77AFC1C51B wds:Q44648441-2780680C-ED38-4A15-B9E8-4D83EBD2F09C wds:Q70618512-ED337D81-995D-4E09-A4D7-119C07EAB04F wds:Q36773681-1D57DF52-E043-42DC-88AC-7F8EC9F4B780 wds:Q36132542-DE8B70C2-C145-4DC7-A7DD-CA3A01E15F9D wds:Q35071595-B9AD536A-225F-43BC-807C-EBB0FEA6967D wds:Q34753527-1A28EEBA-DB34-4EF5-8909-75D2717B4519 wds:Q37534382-B8A443D8-8B77-48E7-A52B-20EF671AE3F7 wds:Q78061973-887CD2C3-E8D5-4E86-B00F-70A3E1BCBEB5 wds:Q35958227-8F2CC2D4-EFF9-4726-B08E-B83D8BB08948 wds:Q38586834-3F74C670-C9DD-4138-983E-CE6EB507B109 wds:Q36403677-9B0B4F25-28E1-40A2-874D-BFD14C6D1A2E wds:Q36674362-37337CBF-41A5-4FEA-958D-D5EA34529C74 wds:Q44006849-3A3FB38B-4236-46FF-9C20-D3444F6BAF37 wds:Q43636277-8799BA96-CFCE-4546-98B5-A74FD15960A9 wds:Q36469346-FFC80491-50E7-4014-AFA5-BC274C5C0FA0 wds:Q36649708-A3EF9B4A-AAFE-4629-BB1C-8F9EA478CED2 wds:Q48112911-35FA4767-84AF-429D-9B70-4A0C4DF08D1D wds:Q71191890-7F9972F6-E60B-4825-890C-F2FA8DDAD47E wds:Q72666125-2F73C275-569C-4C60-9681-01461B78DE3A

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software